Top 3D Bioprinting Companies

Published: September 2024

With the growing need for the development of viable complex structures and the challenges associated with the conventional 2D bioprinting, there is an urgent need to develop advanced 3D bioprinting technologies and methods which have the potential to transform healthcare. We analyzed over 65 3D bioprinting companies that are engaged in offering 3D bioprinting solutions. In this article, discover five top 3D bioprinting companies and their capabilities in 3D bioprinting market.

3D bioprinting is an innovative technology combining the capabilities of 3D printing with the principles of biology and medicine. 3D bioprinting involves the precise layering of cells, growth factors, bioinks, and biomaterials to create three-dimensional functional biological structures. Further, this technology has the potential to revolutionize the field of tissue engineering and regenerative medicine by precisely arranging and assembling cellular components facilitating the growth and development of complex tissues and organs. This has ultimately resulted in the advancements in treatments from organ transplants to the regeneration of damaged or diseased tissues. In addition to its applications in tissue engineering, 3D bioprinting also plays a major role in drug testing and personalized medicine. By creating realistic, three-dimensional models of human tissues and organs, researchers can more accurately test the efficacy and safety of new pharmaceutical compounds. Furthermore, this technology can enable the development of personalized treatments tailored to an individual's unique biological characteristics, paving the way for more effective and targeted therapies.

Roots Analysis has conducted an exhaustive study on 3D Bioprinting Market featuring the current market landscape and future opportunity for the companies engaged in developing 3D bioprinting solutions, over a span of 11 years.

Below, we have listed (in alphabetical order), the top five 3D Bioprinting companies:

Allevi
CELLINK
Organovo
Regemat 3D
Rokit Healthcare

Top 5 3D bioprinting Companies

Interested in exploring all 65+ 3D Bioprinting Companies and their recent initiatives?

Discover Below the Details on Five Top 3D Bioprinting Companies

Let us deep dive to understand the activity of the five top 3D bioprinting companies (companies offering all types of components and offerings for clinical trials and research centers, and academic institutes) in the 3D bioprinting market. It is essential to note that the selection of top players can differ substantially according to the defined criteria.

Allevi Entered into a Collaboration with The Wistar Institute to Advance Covid-19 Research Through the Implementation of 3D Bioprinting Processes

1. Allevi

Allevi is a company that specializes in bioprinting technology. Further, the company develops 3D bioprinters along with bioinks that are used in various applications within the field of biotechnology and regenerative medicine. Moreover, Allevi's technology allows researchers and scientists to create complex 3D biological structures, such as tissues and organs, for research purposes, drug testing, and organ transplantations.

Allevi: Company Overview

Key Parameters	Description
Company Logo
Year of Establishment	2014
Number of Employees	11-50
Headquarters	Pennsylvania, US

The company strives to provide 3D bioprinting solutions that enable its global clientele to set up bioprinting systems, which are more efficient and economical. In May 2021, the company was acquired by 3D Systems in order to further expand the initiatives focused on regenerative medicine to accelerate growth in the research laboratories of medical and pharmaceutical.

Further details on recent initiatives taken by Allevi and other 3D bioprinting companies have been provided in detail in the report.

Between FY2021-2023, the Company’s Bioprinting Business Segment Revenues Increased at an Annualized Rate of 34.6%

2. CELLINK

CELLINK is a subsidiary of BICO, focused on the manufacturing and development of 3D bioprinters which involves the use of printing technologies with applications in 3D cell culturing, tissue engineering, and bio fabrication. It is interesting to note that, in 2016, the company launched the world's first universal bioink, making high-quality bioinks readily available for researchers focusing on 3D bioprinting domain. Notably, the company's bioinks are used by industry leaders such as academic institutes and researcher centers, with over 700 publications referencing CELLINK's innovations.

CELLINK: Company Details

Key Parameters	Description
Company Logo
Year of Establishment	2016
Number of Employees	201-500
Headquarters	Gothenburg, Sweden

In October 2023, CELLINK collaborated with the University of California to establish a 3D bioprinting Centre of Excellence in order to utilize various bioprinting technologies.

Further details on recent initiatives taken by CELLINK and other 3D bioprinting companies have been provided in detail in the report.

In 2022, Regemat 3D Raised USD 0.5 million Through Equity Crowdfunding to Advance its 3D Bioprinting Technology

3. Regemat 3D

Regemat 3D is a company that focuses on bioprinting technology. Further, the company is well known for their innovative work in the field of 3D bioprinting, which involves creating 3 dimensional structures by using biological biomaterials. Moreover, Regemat 3D specializes in developing various 3D bioprinting solutions for multiple application areas, such as tissue engineering, regenerative medicine and organ transplantation. It is worth mentioning that the company’s technology aims to revolutionize the healthcare industry by providing personalized medical solutions through the use of 3D bioprinting.

Regemat 3D: Company Overview

Key Parameters	Description
Company Logo
Year of Establishment	2015
Number of Employees	11-50
Headquarters	Andalusia, Spain

In June 2022, Regemat 3D entered into a strategic partnership with Humabiologics in order to provide the European market with the human-derived printed biomaterials. In December 2020, Regemat 3D entered into a collaboration with Xpect INX to provide advanced bioprinting solutions such as bioinks which are used with versatile systems and would result in the substitutes for various human tissues.

Further details on recent initiatives taken by Regemat 3D and other 3D bioprinting companies have been provided in detail in the report.

In the Q1 FY2024, Organovo Reported Revenues of USD 0.1 million, a Decrease of 19.2% From the Revenues Reported During the Same Time Last Year

4. Organovo

Organvovo is an American biotechnology company that specializes in 3D bioprinting technology for creating human tissues for medical research and various other therapeutic applications. Further, the firm claims to be at the forefront of developing innovative solutions for drug discovery, disease modeling, and regenerative medicine by printing functional human tissues. Moreover, Organovo's advanced bioprinting technology has the potential to revolutionize the pharmaceutical and healthcare industries by providing more accurate models for drug testing and personalized medicine.

Organovo: Company Overview

Key Parameters	Description
Company Logo
Year of Establishment	2007
Number of Employees	11-50
Headquarters	California, US

In May 2024, Organovo raised USD 5.25 million through public offerings. The company aimed to use the funding amount to check the efficacy of drugs in the 3D human tissue models. In February 2022, Organovo entered into a strategic partnership with BICO (CELLINK) in order to license patent portfolios of the former company in the 3D bioprinting domain.

Further details on recent initiatives taken by Organovo and other 3D bioprinting companies have been provided in detail in the report.

In July 2020, DRADS Capital Invested in Rokit Healthcare Through Series C Funding Round in Order to Develop Innovative Bioprinting Techniques

5. Rokit Healthcare

Rokit Healthcare is a company that specializes in the field of bioprinting and regenerative medicine. The company is involved in the development of 3D bioprinting technology, which involves creating living tissues and organs for medical applications. Further, the firm applies artificial Intelligence as well as 3D bioprinting technology in order to redevelop the skin and cartilage organs. Moreover, their focus on bioprinting technology has the potential to significantly impact the future of healthcare by offering customized and regenerative treatment options for patients.

Rokit Healthcare: Company Overview

Key Parameters	Description
Company Logo
Year of Establishment	2012
Number of Employees	51-200
Headquarters	Seoul, South Korea

In February 2019, Rokit Healthcare secured capital investment worth KRW 11 Billion through venture capital funding rounds in order to develop organ regeneration platform.

Further details on recent initiatives taken by Rokit Healthcare and other 3D bioprinting companies have been provided in detail in the report.

What About the Other 3D Bioprinting Companies Around the World?

The above presentation features five top 3d bioprinting companies selected from a pool of over 65 players that we have compiled. If you're interested, you can download the Sample Report on this topic by Roots Analysis. For personalized assistance in identifying the most relevant solutions based on your specific criteria, please don't hesitate to reach out to us at sales@rootsanalysis.com.